Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis-Reference-Cited by-同舟云学术

Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis

Published:2021-06-23 Issue:6 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Holland Poppy¹,Jahnke Nikki²

Affiliation:

1. West of Scotland Adult CF Unit; Queen Elizabeth University Hospital (The Southern General Hospital); Glasgow UK

2. Department of Women's and Children's Health; University of Liverpool; Liverpool UK

Publisher

Wiley

Subject

Pharmacology (medical)

Reference130 articles.

1. Costantini D Padoan R Brienza A Lodi G Assael BM Giunta A Clinical evaluation of carbenicillin and sisomycin alone or in combination in CF patients with pulmonary exacerbations Proceedings of the 11th European Cystic Fibrosis Conference 1982 227

2. Evaluation of antibiotic therapy in patients with cystic fibrosis;Huang;Chest,1979

3. Huang NN Palmer J Braverman S Keith HH Schidlow D Therapeutic efficacy of ticarcillin and carbenicillin in patients with cystic fibrosis: a double blind study 23rd Cystic Fibrosis Club Abstracts; 1982 May 14; Washington DC 1982 124

4. Once daily tobramycin monotherapy versus conventional antibiotic therapy for the treatment of pseudomonal pulmonary exacerbations in cystic fibrosis patients;Master;European Respiratory Journal,1997

5. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study;Master;Pediatric Pulmonology,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antipseudomonal treatment decisions during CF exacerbation management;Journal of Cystic Fibrosis;2022-09

2. The Elusive Role of Airway Infection in Cystic Fibrosis Exacerbation;Journal of the Pediatric Infectious Diseases Society;2022-09-01